Glaukos (GKOS) Stock Price
$84.48 2.5%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
7 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Glaukos, AI stock picks, stock alerts and much more.
GKOS AI Stock Analysis
AI stock analysis for GKOS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Glaukos (GKOS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Glaukos (GKOS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Glaukos (GKOS), currently trading at $84.48, will... Sign up to access price prediction.
About GKOS
-
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
-
Symbol
GKOS
-
Market
NYSE
-
Industry
Medical - Devices
-
Market Cap
4.8B
Similar Stocks
 |
Abbott Laboratories ABT |
$133.5 0.2% |
6 |
 |
Boston Scientific BSX |
$96.38 0.3% |
7 |
 |
Edwards Lifesciences EW |
$76.97 0.5% |
6 |
 |
Medtronic MDT |
$98.55 0.1% |
7 |
 |
Stryker SYK |
$369.8 1% |
7 |
News
GKOS Alternative Data
Web Traffic
Glaukos receives an estimated 23297 monthly visitors to glaukos.com.
-
Web Traffic
23297
-
Change from Previous Month
17.6%
-
3 Month Change
13.7%
-
YoY Change
13.7%
Facebook Engagement
Glaukos has engaged 392 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
392
-
Daily Change
4%
-
1 Month Change
27.7%
-
3 Month Change
11.4%
-
YoY Change
11.4%
LinkedIn Followers
32,543 are following Glaukos on LinkedIn, up by 2% over the last month.
-
LinkedIn Followers
32543
-
Daily Change
0.1%
-
1 Month Change
2%
-
3 Month Change
6.1%
-
YoY Change
6.1%
Job Postings
Glaukos has an estimated 21 open job postings, which is down -27.6% over the last month.
-
Job Postings
21
-
Daily Change
0%
-
1 Month Change
27.6%
-
3 Month Change
16%
-
YoY Change
16%
LinkedIn Employees
According to LinkedIn, Glaukos has 974 employees, up by 0.3% over the last month.
-
LinkedIn Employees
974
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Reddit Mentions
Glaukos has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Glaukos has 1,642 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
1642
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
1%
-
YoY Change
1%
Instagram Followers
Glaukos has 3,647 Instagram Followers on its main Instagram account, up by 1.8% over the last month.
-
Instagram Followers
3647
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
5.4%
-
YoY Change
5.4%
Business Outlook
According to employee reviews, the business outlook among employees at Glaukos is 91 out of 100 (very bullish).
-
Business Outlook
91
-
Change from Previous Month
2.2%
-
3 Month Change
2.2%
-
YoY Change
2.2%
News Mentions
Glaukos was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
GKOS Financials
GKOS Key Metrics
-
Total Revenue
$106.7M
-
Net Income
-$18.1M
-
Earnings per Share
-$0.32
-
Free cash flow
-$20.5M
-
EBITDA
-$20.7M
-
EBITDA Ratio
-0.193861
-
Total Assets
$966.2M
GKOS 2-year Revenue & Income
GKOS 2-year Free Cash Flow
GKOS Technicals
GKOS SMA
GKOS RSI
FAQ
What's the current price of Glaukos (GKOS) Stock?
The price of an Glaukos (GKOS) share is $84.48.
What's the market cap of Glaukos?
The current market cap of Glaukos is 4.8B.
What are some stocks similar to Glaukos (GKOS) that investors often compare it to?
Glaukos (GKOS) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.
What is the forecast for Glaukos' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Glaukos' stock price to be around $92.02 in 2026. Starting from the current price of $84.48, this represents a 8.9% change in price, indicating a bullish outlook for the stock.
How to buy Glaukos (GKOS) Stock?
Glaukos stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Glaukos shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.